M Rotger

Discipline

Economies et finances (1) Anthropologie biologique (1)

Type de document

Articles (15)

Co-auteur

Date

Source

Mot-clé

Treatment (12) Human beings (10) association (9) Methods (9) Social groups (9) Methods (9) cohorte (9) thérapie (8) Therapeutics (8) virus (7) risque (7) effet (7) Immunodeficiency (7) Risk (7) analyse (6) Population (6) Patients (6) Analysis (6) Population (6) Patients (6) Ci (Chinese poetry) (5) Example (5) Models (5) art (4) modèle (4) adulte (4) Art (4) Art (4) Genes (4) Forecasting (4)

Documents écrit par M Rotger (15) | parle de M Rotger (0)

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
V. Lodermeyer et al. (15 juil. 2018)
Privacy-preserving genomic testing in the clinic: a model using HIV treatment.
P.J. McLaren et al.
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.
T. Junier et al. (2016)
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
H. Kovari et al. (2015)
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
N.W. Cummins et al. (2015)
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
M. Arab-Alameddine et al. (2014)
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
M. Rotger et al. (2013)
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
T.R. Glass et al.
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
J. di Iulio et al.
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
M. Rotger et al. (2010)
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
M. Rotger et al. (2010)
CCL3L1 and HIV/AIDS susceptibility.
T.J. Urban et al. (2009)
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.
S. Colombo et al. (2008)
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
M. Rotger et al.
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
P.E. Tarr et al. (2005)